The CRISPR screening CERES of EZH1/EZH2 were negative in different BC cell lines, including TNBC cells, thus indicating that EZH1/EZH2 may be important in the proliferation and survival of BC cells (Fig. 5D). The gene discussed is EZH1; the disease is breast cancer.